Cargando…
The Type of Responder T-Cell Has a Significant Impact in a Human In Vitro Suppression Assay
BACKGROUND: In type 1 diabetes (T1D), a prototypic autoimmune disease, effector T cells destroy beta cells. Normally, CD4(+)CD25(+high), or natural regulatory T cells (Tregs), counter this assault. In autoimmunity, the failure to suppress CD4(+)CD25(low) T cells is important for disease development....
Autores principales: | Jana, Srikanta, Campbell, Hope, Woodliff, Jeffrey, Waukau, Jill, Jailwala, Parthav, Ghorai, Jugal, Ghosh, Soumitra, Glisic, Sanja |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997082/ https://www.ncbi.nlm.nih.gov/pubmed/21151941 http://dx.doi.org/10.1371/journal.pone.0015154 |
Ejemplares similares
-
At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction
por: Glisic-Milosavljevic, Sanja, et al.
Publicado: (2007) -
Apoptosis of CD4(+)CD25(high) T Cells in Type 1 Diabetes May Be Partially Mediated by IL-2 Deprivation
por: Jailwala, Parthav, et al.
Publicado: (2009) -
Interaction between Treg Apoptosis Pathways, Treg Function and HLA Risk Evolves during Type 1 Diabetes Pathogenesis
por: Glisic, Sanja, et al.
Publicado: (2012) -
Histone H2AX deficiency causes neurobehavioral deficits and impaired redox homeostasis
por: Weyemi, Urbain, et al.
Publicado: (2018) -
New concepts of inverse fuzzy mixed graphs and its application
por: Poulik, Soumitra, et al.
Publicado: (2021)